Novel evidence on sepsis-inducing pathogens: from laboratory to bedside
Frontiers in Microbiology · 23.06.2023 · 14
DOI: 10.3389/fmicb.2023.1198200 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 23.06.2023. Verfasst von Sebastian Gatica und 10 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 277 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico, Millennium Institute on Immunology and Immunotherapy.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a life-threatening condition and a significant cause of preventable morbidity and mortality globally. Among the leading causative agents of sepsis are bacterial pathogens Escherichia coli , Klebsiella pneumoniae , Staphylococcus aureus , Pseudomonas aeruginosa , and Streptococcus pyogenes , along with fungal pathogens of the Candida species. Here, we focus on evidence from human studies but also include in vitro and in vivo cellular and molecular evidence, exploring how bacterial and fungal pathogens are associated with bloodstream infection and sepsis. This review presents a narrative update on pathogen epidemiology, virulence factors, host factors of susceptibility, mechanisms of immunomodulation, current therapies, antibiotic resistance, and opportunities for diagnosis, prognosis, and therapeutics, through the perspective of bloodstream infection and sepsis. A list of curated novel host and pathogen factors, diagnostic and prognostic markers, and potential therapeutical targets to tackle sepsis from the research laboratory is presented. Further, we discuss the complex nature of sepsis depending on the sepsis-inducing pathogen and host susceptibility, the more common strains associated with severe pathology and how these aspects may impact in the management of the clinical presentation of sepsis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile.
- Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.
- Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Millennium Institute on Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Departamento de Endocrinología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Förderung
- Fondo Nacional de Desarrollo Científico y Tecnológico
- Millennium Institute on Immunology and Immunotherapy
Zitieren
APA
Gatica, S., Fuentes, B., Rivera-Asín, E., Ramírez-Céspedes, P., Sepúlveda-Alfaro, J., Catalán, E. A., Bueno, S. M., Kalergis, A. M., Simon, F., Riedel, C. A., & Melo-Gonzalez, F. (2023). Novel evidence on sepsis-inducing pathogens: from laboratory to bedside. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1198200
Vancouver
Gatica S, Fuentes B, Rivera-Asín E, Ramírez-Céspedes P, Sepúlveda-Alfaro J, Catalán EA, et al. Novel evidence on sepsis-inducing pathogens: from laboratory to bedside. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1198200
BibTeX
@article{Gatica2023,
author = {Gatica, Sebastian and Fuentes, Brandon and Rivera-Asín, Elizabeth and Ramírez-Céspedes, Paula and Sepúlveda-Alfaro, Javiera and Catalán, Eduardo A and Bueno, Susan M and Kalergis, Alexis M and Simon, Felipe and Riedel, Claudia A and Melo-Gonzalez, Felipe},
title = {Novel evidence on sepsis-inducing pathogens: from laboratory to bedside},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1198200}
}
EUVIMED